Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, AGTC, Altimmune, Asalyxa, Bioage, Brainstorm Cell, Cabaletta, Carisma, Contrafect, Cyclerion, Elixiron, Intravacc, Mediwound, Merck, Morphic, Otsuka, Oxford, Proteus, PT Bio, Sinovac, Starpharma, Sutro, Therapyx, Vektor, Vericel, Xphyto.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bavarian Nordic, Bristol Myers Squibb, Byondis, Immunovant, Ipsen, Krystal, Mereo, Ovid, Takeda, Union.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: MDIC.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brainsway, Guardant Health, Helixbind.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Medical Systems, Allied Bioscience, Beckman Coulter, Ben-Gurion University, Biobridge Global, Bionano Genomics, Clinical Laserthermia Systems, Cytosorbents, Diomics, Enterprise Singapore, Fgc Health, Lineagen, Lumiata, Mw Industries, Nex Cubed, Nn, Qiagen, Restalyst, Roche, Siemens, Terumo, Todos Medical, Xbiotech.

HONG KONG – Last week was a busy one for Harbour Biomed Therapeutics Ltd., seeing the company sign a COVID-19 research collaboration with several Dutch institutions as well as lodge an application to list on the Hong Kong Stock Exchange.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aligos, Editas, Exelixis, HHS, Kazia, Merck, Turning Point.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aimmune, Beigene, Biobridge, Bio-Thera, Bristol Myers Squibb, Cancer Genetics, Cassava, Compass, Cytrx, Eyepoint, Forbius, Harbour, Hercules, Immunitybio, Immunogenesis, Innovation, Medexus, Moderna, Nantkwest, Organicell, Proteostasis, Stemonix, Vir, Xbiotech, Yumanity.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adrenomed, Aslan, Celldex, Cohbar, Cynata, Geovax, Mitsubishi Tanabe, Novartis, Novavax, Odonate, Onconova, Protalix, PTC, Reithera, Trevena.